Kane’s first FDA cleared medical device aims to disrupt global wound care hydrogel marketWINNIPEG, Manitoba, May 25, 2023 Kane Biotech Inc. announces that on May 24, 2023 it received 510. | May 25, 2023
ProgenaCare to commercialize coactiv+™ Antimicrobial Wound Gel in the U.S. wound care marketWINNIPEG, Manitoba, April 20, 2023 Kane Biotech Inc. announced today that it has signed a. | April 20, 2023
Also, the William R. Kenan Jr. Charitable Trust has chosen its next leader, and the Doris Duke Charitable Foundation tapped a new chief program officer.